During the pandemic, pharmaceutical companies paid $690 million in secret third-party royalties to Dr. Anthony Fauci's NIAID, revealing significant conflicts of interest within the agency.
During the pandemic, payments from private pharmaceutical companies under murky licensing and royalty schemes exploded to Dr. Anthony Fauci's agency and colleagues.
The public in America began to sense that Big Pharma and Big Government were closely related. We now have more information, and it does not give us confidence, thanks to our two federal cases demanding openness.
Pharmaceutical and healthcare corporations contributed $710,381,160 in third-party royalties to the National Institutes of Health in 2022 and 2023. Healthcare organizations licensed discoveries developed in federal labs that were funded by taxpayers, and in exchange, NIH, its leadership, and scientists received compensation. Less than $5 million was the two-year average of these payments over the previous ten years...
Full Access
Included:
-
Access to All Articles.
-
One Plan. No Tiers.
-
No Ads.
-
Cancel anytime.
